Detalhe da pesquisa
1.
Combination Immune Checkpoint Blockade Enhances IL-2 and CD107a Production from HIV-Specific T Cells Ex Vivo in People Living with HIV on Antiretroviral Therapy.
J Immunol
; 208(1): 54-62, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34853078
2.
Cell-Associated Human Immunodeficiency Virus (HIV) Ribonucleic Acid Has a Circadian Cycle in Males With HIV on Antiretroviral Therapy.
J Infect Dis
; 225(10): 1721-1730, 2022 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34655216
3.
Intrahepatic CXCL10 is strongly associated with liver fibrosis in HIV-Hepatitis B co-infection.
PLoS Pathog
; 16(9): e1008744, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32898182
4.
Diverse effects of interferon alpha on the establishment and reversal of HIV latency.
PLoS Pathog
; 16(2): e1008151, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32109259
5.
Combination Immune Checkpoint Blockade to Reverse HIV Latency.
J Immunol
; 204(5): 1242-1254, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31988180
6.
Impact of Anti-PD-1 and Anti-CTLA-4 on the Human Immunodeficiency Virus (HIV) Reservoir in People Living With HIV With Cancer on Antiretroviral Therapy: The AIDS Malignancy Consortium 095 Study.
Clin Infect Dis
; 73(7): e1973-e1981, 2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33677480
7.
Longitudinal analysis of subtype C envelope tropism for memory CD4+ T cell subsets over the first 3 years of untreated HIV-1 infection.
Retrovirology
; 17(1): 24, 2020 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32762760
8.
Persistence of envelopes in different CD4+ T-cell subsets in antiretroviral therapy-suppressed people with HIV.
AIDS
; 37(2): 247-257, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36541637
9.
HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy.
EBioMedicine
; 87: 104391, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36502576
10.
Neurotoxicity with high-dose disulfiram and vorinostat used for HIV latency reversal.
AIDS
; 36(1): 75-82, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34586085
11.
Memory CD4+ T cells that co-express PD1 and CTLA4 have reduced response to activating stimuli facilitating HIV latency.
Cell Rep Med
; 3(10): 100766, 2022 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36198308
12.
The impact of immune checkpoint therapy on the latent reservoir in HIV-infected individuals with cancer on antiretroviral therapy.
AIDS
; 35(10): 1631-1636, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33859108
13.
Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency.
EBioMedicine
; 65: 103241, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33647768
14.
A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controls.
EBioMedicine
; 65: 103252, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33640794
15.
A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection.
J Virus Erad
; 6(3): 100004, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33251022
16.
The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trial.
Lancet HIV
; 5(5): e221-e230, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29643011
17.
Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latency.
AIDS
; 32(11): 1491-1497, 2018 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29746296
18.
Variation in cell-associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator brain-and-muscle-ARNT-like-1.
AIDS
; 32(15): 2119-2128, 2018 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30005017
19.
Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome.
AIDS
; 31(13): 1839-1845, 2017 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28514279
20.
No adverse safety or virological changes 2 years following vorinostat in HIV-infected individuals on antiretroviral therapy.
AIDS
; 31(8): 1137-1141, 2017 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28301423